We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
1026
Genpact
G
$5.96B
$4.19M 0.01%
172,307
+12,185
+8% +$290K
UFS
1027
DELISTED
DOMTAR CORPORATION (New)
UFS
$4.19M 0.01%
107,419
+8,796
+9% +$335K
GPK icon
1028
Graphic Packaging
GPK
$3.17B
$4.19M 0.01%
335,795
+32,363
+11% +$418K
CPN
1029
DELISTED
Calpine Corporation
CPN
$4.19M 0.01%
366,373
+31,723
+9% +$374K
BGS icon
1030
B&G Foods
BGS
$287M
$4.17M 0.01%
95,317
+4,718
+5% +$209K
FSLR icon
1031
First Solar
FSLR
$22.7B
$4.16M 0.01%
129,655
+16,162
+14% +$567K
SJI
1032
DELISTED
South Jersey Industries, Inc.
SJI
$4.16M 0.01%
123,377
-2,943
-2% -$91.8K
NBIX icon
1033
Neurocrine Biosciences
NBIX
$16.8B
$4.15M 0.01%
107,220
+7,681
+8% +$348K
ANET icon
1034
Arista Networks
ANET
$227B
$4.15M 0.01%
685,648
+60,672
+10% +$339K
RLI icon
1035
RLI Corp
RLI
$5.62B
$4.14M 0.01%
131,080
+128
+0.1% +$3.96K
EVR icon
1036
Evercore
EVR
$12.4B
$4.13M 0.01%
60,048
+2,958
+5% +$182K
B
1037
DELISTED
Barnes Group Inc.
B
$4.11M 0.01%
86,739
-3,161
-4% -$138K
KBR icon
1038
KBR
KBR
$4.62B
$4.11M 0.01%
245,947
+15,893
+7% +$253K
FUL icon
1039
H.B. Fuller
FUL
$2.97B
$4.1M 0.01%
84,895
+2,181
+3% +$101K
EFOR
1040
Everforth Inc
EFOR
$1.17B
$4.1M 0.01%
92,834
+3,106
+3% +$123K
MGEE icon
1041
MGE Energy Inc
MGEE
$3B
$4.1M 0.01%
62,792
-951
-1% -$56.8K
MASI
1042
DELISTED
Masimo
MASI
$4.09M 0.01%
60,643
+1,588
+3% +$97.6K
VR
1043
DELISTED
Validus Hold Ltd
VR
$4.08M 0.01%
74,262
+8,861
+14% +$468K
HCSG icon
1044
Healthcare Services Group
HCSG
$1.6B
$4.07M 0.01%
103,844
+424
+0.4% +$16.2K
INVX
1045
Innovex International
INVX
$1.96B
$4.07M 0.01%
67,744
+4,207
+7% +$234K
GWRE icon
1046
Guidewire Software
GWRE
$12.6B
$4.05M 0.01%
82,069
+6,290
+8% +$353K
CHS
1047
DELISTED
Chicos FAS, Inc.
CHS
$4.05M 0.01%
281,254
+2,885
+1% +$39.8K
HLF icon
1048
Herbalife
HLF
$1.29B
$4.04M 0.01%
167,952
+13,516
+9% +$369K
LCII icon
1049
LCI Industries
LCII
$2.49B
$4.04M 0.01%
37,463
+562
+2% +$55.9K
JNS
1050
DELISTED
Janus Capital Group Inc
JNS
$4.03M 0.01%
303,809
-8,417
-3% -$116K

Similar funds

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.